In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Top Cited Papers
- 1 May 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 112 (1), 26-34
- https://doi.org/10.1016/j.jconrel.2006.01.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticlesProceedings of the National Academy of Sciences of the United States of America, 2005
- Dendritic-cell trafficking to lymph nodes through lymphatic vesselsNature Reviews Immunology, 2005
- Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticlesJournal of Controlled Release, 2005
- DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cellsAdvanced Drug Delivery Reviews, 2005
- Characterization of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cellsVaccine, 2004
- In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell VaccinationThe Journal of Experimental Medicine, 2004
- Ligand-Specific Targeting of Microspheres to Phagocytes by Surface Modification with Poly(L-Lysine)-Grafted Poly(Ethylene Glycol) ConjugatePharmaceutical Research, 2003
- Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceThe Journal of Experimental Medicine, 2002
- Chemokines and Cell Migration in Secondary Lymphoid OrgansScience, 1999
- Dendritic cells and the control of immunityNature, 1998